Skip to main content
Caplight Logo









MetaDeq

MetaDeq

Private
LondonHealthcare & Life Scienceshttps://metadeq.com/

Company Overview

MetaDeq is a diagnostics company that develops non-invasive, blood-based diagnostic tests for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

medical diagnosticsliver fibrosisMASHmetabolic dysfunction-associated steatohepatitisnon-invasive biopsyliquid biopsybiomarker diagnosticscompanion diagnosticsclinical trial screeningpredictive algorithmliver disease monitoringMASLDmetabolic dysfunction-associated steatotic liver diseaseAI diagnosticsCRO services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MetaDeq Comparables

Compare MetaDeq with similar companies based on industry and business-model similarity.

MetaDeq comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hepta Bio
87%
Fibronostics
86%
AGED Diagnostics
86%

MetaDeq Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

David Nikodem

Chief Executive Officer

Executive Team

MetaDeq Filings

Explore SEC and related filing metadata, where available.

MetaDeq filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MetaDeq's valuation, stock price, and market status.

Is MetaDeq a public or private company?

MetaDeq is a private company.

What is the current stock price of MetaDeq?

MetaDeq is a private company with no public stock price. No recent secondary market data is available.

How much is MetaDeq worth (valuation)?

Valuation information for MetaDeq is not publicly available.

Can I buy MetaDeq stock?

MetaDeq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MetaDeq's last funding round?

Funding round information for MetaDeq is not publicly available.

Who are the main investors in MetaDeq?

Investor information for MetaDeq is not publicly disclosed.

Will MetaDeq IPO soon?

No public IPO plans have been announced for MetaDeq.

How can I track MetaDeq secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MetaDeq's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range7
Year Founded2019
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?